Table 1.

Characteristics of study patients, overall and by sex.

	Overall (n=74)	Males (n = 277)	Females (n = 197)	p
Age (years)	54.10 ± 7.27	54.09 ± 7.49	54.12 ± 6.97	0.962
Obese (BMI > 30)	153 (32.3%)	92 (33.2%)	61 (31.0%)	0.606
Smokers	111 (23.4%)	69 (24.9%)	42 (21.3%)	0.363
Diabetics	73 (15.4%)	52 (18.8%)	21 (10.7%)	0.016
Hyperlipidaemic	314 (66.2%)	174 (62.8%)	140 (71.1%)	0.038
BMI	28.72 ± 4.71	28.91 ± 4.14	28.46 ± 5.41	0.310
Waist circumference	96.04 ± 12.38	100.10 ± 9.99	90.28 ± 13.15	0.000
Glucose (mg/dL)	100.28 ± 28.04	103.32 ± 30.76	95.94 ± 23.00	0.006
Cholesterol/HDL ratio	4.12 ± 1.09	4.38 ± 1.12	3.76 ± 0.94	0.000
Total cholesterol (mg/dL)	214.70 ± 35.92	211.70 ± 36.17	218.92 ± 35.22	0.031
HDL-C (mg/dL)	54.85 ± 14.44	50.54 ± 12.34	60.92 ± 15.01	0.000
LDL-C (mg/dL)	134.18 ± 32.99	134.37 ± 32.46	133.92 ± 33.83	0.888
Triglycerides (mg/dL)	115.26 ± 73.81	137.79 ± 80.32	128.38 ± 61.47	0.001
Systolic blood pressure (mmHg)	140.99 ± 18.92	142.86 ± 16.49	138.37 ± 21.65	0.011
Diastolic blood pressure (mmHg)	89.09 ± 10.40	89.70 ± 9.67	88.24 ± 11.32	0.132
Antihypertensive drugs	271 (57.2%)	159 (57.4%)	112 (56.9%)	0.905
Lipid lowering drugs	75 (15.8%)	52 (18.8%)	23 (11.7%)	0.037
CVR by SCORE*	2.97 ± 4	3.94 ± 4.66	1.61 ± 2.18	0.000
CVR by D'Agostino**	18.00 ± 13.45	22.88 ± 14.66	11.12 ± 7.22	0.000

Hyperlipidaemic: cholesterol > 200 mg/dl. BMI: body mass index; HDL: high-density lipoprotein; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol. CVR: cardiovascular risk. Significant differences between males and females. P value: Differences between males and females. Data are shown as mean ± standard deviation or as number and percentages. *Cardiovascular mortality risk as percent risk and estimated at 10 years. **Cardiovascular morbidity and mortality risk as percent risk and estimated at 10 years.